Timo Möttönen

6.8k total citations
114 papers, 4.6k citations indexed

About

Timo Möttönen is a scholar working on Rheumatology, Hematology and Genetics. According to data from OpenAlex, Timo Möttönen has authored 114 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Rheumatology, 24 papers in Hematology and 15 papers in Genetics. Recurrent topics in Timo Möttönen's work include Rheumatoid Arthritis Research and Therapies (70 papers), Systemic Lupus Erythematosus Research (35 papers) and Autoimmune and Inflammatory Disorders Research (18 papers). Timo Möttönen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (70 papers), Systemic Lupus Erythematosus Research (35 papers) and Autoimmune and Inflammatory Disorders Research (18 papers). Timo Möttönen collaborates with scholars based in Finland, United States and Denmark. Timo Möttönen's co-authors include Pekka Hannonen, Hannu Kautiainen, Marjatta Leirisalo‐Repo, Marjo Lehtonen-Veromaa, Markku Korpela, Kerttu Irjala, Tuulikki Sokka, Kari Puolakka, Reijo Luukkainen and Ilpo Nuotio and has published in prestigious journals such as The Lancet, The Journal of Immunology and PLoS ONE.

In The Last Decade

Timo Möttönen

114 papers receiving 4.3k citations

Peers

Countries citing papers authored by Timo Möttönen

Since Specialization

Citations

This map shows the geographic impact of Timo Möttönen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Möttönen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Möttönen more than expected).

Fields of papers citing papers by Timo Möttönen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Möttönen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Möttönen. The network helps show where Timo Möttönen may publish in the future.

Co-authorship network of co-authors of Timo Möttönen

This figure shows the co-authorship network connecting the top 25 collaborators of Timo Möttönen. A scholar is included among the top collaborators of Timo Möttönen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Möttönen. Timo Möttönen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial 2017 ·PLoS ONE ·(unknown), Katriina Vuolteenaho, Hannu Kautiainen, Riina Nieminen, Timo Möttönen, Pekka Hannonen, Markku Korpela, Markku Kauppi, Kari Laiho, Oili Kaipiainen‐Seppänen, Riitta Luosujärvi, (unknown), Toini Uutela, Marjatta Leirisalo‐Repo, Eeva Moilanen, (unknown)	35
2	A nationwide cross-sectional overview of patients with rheumatoid arthritis followed in outpatient specialty clinics in Finland 2014 ·Scandinavian Journal of Rheumatology ·(unknown), Tuulikki Sokka, Timo Möttönen, Markku Korpela, (unknown), (unknown), (unknown), Toini Uutela, Heikki Valleala, (unknown)	4
3	Decline in work disability caused by early rheumatoid arthritis: results from a nationwide Finnish register, 2000–8 2012 ·Annals of the Rheumatic Diseases ·Vappu Rantalaiho, Hannu Kautiainen, Salme Järvenpää, Lauri J. Virta, Timo Pohjolainen, Markku Korpela, Timo Möttönen, Kari Puolakka	28
4	Consistency of assessments and willingness to pay for a reduction in morning symptoms over time in patients with rheumatoid arthritis 2012 ·Scandinavian Journal of Rheumatology ·R Tuominen, (unknown), Timo Möttönen	1
5	Correlation of 18F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs 2012 ·European Journal of Nuclear Medicine and Molecular Imaging ·Anne Roivainen, (unknown), Timo Möttönen, Pirjo Nuutila, Vesa Oikonen, Riitta Parkkola, Luminita Pricop, (unknown), Nicholas Seneca, Marko Seppänen, Timo Yli‐Kerttula	55
6	Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial 2010 ·Arthritis Research & Therapy ·Vappu Rantalaiho, Markku Korpela, Leena Laasonen, Hannu Kautiainen, Salme Järvenpää, Pekka Hannonen, Marjatta Leirisalo‐Repo, Harri Blåfield, Kari Puolakka, Anna Karjalainen, Timo Möttönen, (unknown)	78
7	Willingness to pay for improvement of physical function among rheumatoid arthritis patients as measured by Health Assessment Questionnaire 2009 ·Rheumatology International ·Risto Tuominen, (unknown), (unknown), Timo Möttönen	10
8	Combination drug strategy in recent‐onset rheumatoid arthritis suppresses collagen I degradation and is associated with retardation of radiological progression 2008 ·Scandinavian Journal of Rheumatology ·Markku Hakala, Juha Risteli, (unknown), Hannu Kautiainen, Markku Korpela, Pekka Hannonen, Marjatta Leirisalo‐Repo, Leena Laasonen, Leena Paimela, Timo Möttönen, (unknown)	6
9	Cost of Finnish statutory inpatient rehabilitation and its impact on functional and work capacity of patients with early rheumatoid arthritis: experience from the FIN‐RACo trial 2007 ·Scandinavian Journal of Rheumatology ·Kari Puolakka, Hannu Kautiainen, Timo Möttönen, Pekka Hannonen, Timo Pohjolainen, Markku Korpela, Kaisa Vuori, Kirsti Ilva, U. I. Yli-Kerttula, Pentti A. Järvinen, Marjatta Leirisalo‐Repo	7
10	Use of positron emission tomography with methyl‐¹¹C‐choline and 2‐¹⁸F‐fluoro‐2‐deoxy‐D‐glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium 2003 ·Arthritis & Rheumatism ·Anne Roivainen, Riitta Parkkola, Timo Yli‐Kerttula, Pertti Lehikoinen, Tapio Viljanen, Timo Möttönen, Pirjo Nuutila, Heikki Minn	96
11	Increased Serum Soluble Transferrin Receptor Concentration Detects Subclinical Iron Deficiency in Healthy Adolescent Girls 2003 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Pauli Suominen, Marjo Lehtonen-Veromaa, Timo Möttönen, Jorma Viikari, Allan Rajamäki, Kerttu Irjala	9
12	Combination drug therapy retards the development of rheumatoid atlantoaxial subluxations 2000 ·Arthritis & Rheumatism ·Marko H. Neva, Markku Kauppi, Hannu Kautiainen, Reijo Luukkainen, Pekka Hannonen, Marjatta Leirisalo‐Repo, Martti Nissilä, Timo Möttönen, (unknown)	65
13	A 1-Year Prospective Study on the Relationship between Physical Activity, Markers of Bone Metabolism, and Bone Acquisition in Peripubertal Girls¹ 2000 ·The Journal of Clinical Endocrinology & Metabolism ·Marjo Lehtonen-Veromaa, Timo Möttönen, Kerttu Irjala, Ilpo Nuotio, Aila Leino, Jorma Viikari	84
14	Physical activity and bone mineral acquisition in peripubertal girls 2000 ·Scandinavian Journal of Medicine and Science in Sports ·Marjo Lehtonen-Veromaa, Timo Möttönen, Erkki Svedström, Panu Hakola, Olli J. Heinonen, Jorma Viikari	39
15	Vitamin D intake is low and hypovitaminosis D common in healthy 9− to 15-year-old Finnish girls 1999 ·European Journal of Clinical Nutrition ·Marjo Lehtonen-Veromaa, Timo Möttönen, Kerttu Irjala, M Kärkkäinen, Christel Lamberg‐Allardt, Panu Hakola, Jorma Viikari	189
16	Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with “sawtooth” strategy 1998 ·Annals of the Rheumatic Diseases ·Timo Möttönen, Leena Paimela, Marjatta Leirisalo‐Repo, Hannu Kautiainen, Jorma Ilonen, Pekka Hannonen	108
17	Increase of HLA-DRB10408 and -DQB10301 in HLA-B27 positive reactive arthritis 1997 ·Annals of the Rheumatic Diseases ·(unknown), Helena Reijonen, Jorma Ilonen, Katja Anttila, Simo Nikkari, Timo Möttönen, U. I. Yli-Kerttula, Auli Toivanen	20
18	ASSOCIATION OF IN VITRO IMMUNE FUNCTIONS WITH THE SEVERITY OF THE DISEASE IN RHEUMATOID ARTHRITIS 1993 ·Lara D. Veeken ·Eeva Jokinen, Timo Möttönen, Pekka Hannonen, Heikki Arvilommi	9
19	Clinical sequelae and sacroiliac joint changes by computed tomography after recovery from septic sacroiliitis 1989 ·Clinical Rheumatology ·(unknown), Pekka Hannonen, (unknown), (unknown), Timo Möttönen, M. Oka	8
20	A Comparison of ^99m Tc-MDP and ^99m Tc-Pertechnetate by Computerized Quantitative Joint Scintigraphy 1983 ·Scandinavian Journal of Rheumatology ·Martti Oka, Timo Möttönen, A. Rekonen	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact